<?xml version="1.0" encoding="utf8"?>
 <!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd"> <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">JPHI</journal-id>
      <journal-title-group>
        <journal-title>Journal of Public Health International</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2641-4538</issn>
      <publisher>
        <publisher-name>Open Access Pub</publisher-name>
        <publisher-loc>United States</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.14302/issn.2641-4538.jphi-24-5044</article-id>
      <article-id pub-id-type="publisher-id">JPHI-24-5044</article-id>
      <article-categories>
        <subj-group>
          <subject>research-article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Changes in Cellular Morphology in Bronchoalveolar Lavage Fluid of Children with Mycoplasma Pneumoniae Pneumonia</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Kun</surname>
            <given-names>Ma</given-names>
          </name>
          <xref ref-type="aff" rid="idm1841558860">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shujun</surname>
            <given-names>Li</given-names>
          </name>
          <xref ref-type="aff" rid="idm1841558860">1</xref>
          <xref ref-type="aff" rid="idm1841564476">*</xref>
        </contrib>
      </contrib-group>
      <aff id="idm1841558860">
        <label>1</label>
        <addr-line>Department of Pediatrics, The First Affiliated Hospital of Xinxiang Medical University, No. 88 of Jiankang Road Henan Province, Weihui City, 453100, China.</addr-line>
      </aff>
      <aff id="idm1841564476">
        <label>*</label>
        <addr-line>Corresponding Author </addr-line>
      </aff>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Sasho</surname>
            <given-names>Stoleski</given-names>
          </name>
          <xref ref-type="aff" rid="idm1841428308">1</xref>
        </contrib>
      </contrib-group>
      <aff id="idm1841428308">
        <label>1</label>
        <addr-line>Institute of Occupational Health of R. Macedonia, WHO CC and Ga2len CC</addr-line>
      </aff>
      <author-notes>
        <corresp>Shujun Li, Department of Pediatrics, The First Affiliated Hospital of Xinxiang Medical University, No. 88 of, Jiankang, Road Henan Province, Weihui, City, 453100, China <email>picu3390@126.com</email></corresp>
        <fn fn-type="conflict" id="idm1842527868">
          <p>All of the authors had no any personal, financial, commercial, or academic conflicts of interest separately</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub" iso-8601-date="2024-04-10">
        <day>10</day>
        <month>04</month>
        <year>2024</year>
      </pub-date>
      <volume>7</volume>
      <issue>1</issue>
      <fpage>45</fpage>
      <lpage>51</lpage>
      <history>
        <date date-type="received">
          <day>25</day>
          <month>03</month>
          <year>2024</year>
        </date>
        <date date-type="accepted">
          <day>31</day>
          <month>03</month>
          <year>2024</year>
        </date>
        <date date-type="online">
          <day>10</day>
          <month>04</month>
          <year>2024</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© </copyright-statement>
        <copyright-year>2024</copyright-year>
        <copyright-holder>Kun Ma, et al</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://openaccesspub.org/jphi/article/2098">This article is available from http://openaccesspub.org/jphi/article/2098</self-uri>
      <abstract>
        <sec id="idm1841422044">
          <title>Objective</title>
          <p>To study changes of cell morphology in BALF in children with Mycoplasma pneumoniae pneumonia (MPP).</p>
        </sec>
        <sec id="idm1841423628">
          <title>Methods</title>
          <p>From December 2021 to May 2022, a group of 32 children diagnosed with Acute MPP and admitted for treatment in the Pediatrics Department and PICU of the First Affiliated Hospital of Xinxiang Medical University were                  selected for our study. These patients underwent bronchoalveolar lavage as part of their clinical assessment. For comparison, we included a control group                          comprising 10 children who were not infected but had bronchial foreign bodies. We investigated the cellular composition in the bronchoalveolar lavage fluid (BALF) using Wright-Giemsa staining and microscopic evaluation, aiming to understand the relationship between shifts in cell proportions and extra-pulmonary symptoms associated with MPP. </p>
        </sec>
        <sec id="idm1841422980">
          <title>Results</title>
          <p>In this study, a total of 42 cases were enrolled, with 32 cases in the study group and 10 cases in the control group. There were no statistically significant differences in gender, age, height, weight, and BMI between the two groups (<italic>p</italic> &gt; 0.05). The study group exhibited significantly higher levels of neutrophil                      percentage (GRA%), CRP, D-dimer, and LDH in blood routine tests compared to the control group (<italic>p</italic> &lt; 0.05). Furthermore, the proportions of neutrophils (%) and macrophages (%) in BALF were significantly higher in the study group compared to the control group (<italic>p</italic>&lt; 0.05), while the proportion of lymphocytes (%) in BALF showed no statistically significant difference between the two groups (<italic>p</italic>&gt; 0.05).</p>
        </sec>
        <sec id="idm1841396676">
          <title>Conclusion</title>
          <p>In the acute phase of MPP in children, BALF is predominantly composed of neutrophils. A lower proportion of lymphocytes in BALF is associated with a higher incidence of extra-pulmonary manifestations and longer hospitalization duration.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>cytological morphology</kwd>
        <kwd>bronchoalveolar lavage</kwd>
        <kwd>Mycoplasma pneumoniae pneumonia</kwd>
        <kwd>children</kwd>
      </kwd-group>
      <counts>
        <fig-count count="0"/>
        <table-count count="2"/>
        <page-count count="7"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec id="idm1841397540" sec-type="intro">
      <title>Introduction</title>
      <p>Mycoplasma pneumoniae (MP) is one of the major causes of community-acquired pneumonia in children aged 5 years and older<xref ref-type="bibr" rid="ridm1841922852">1</xref>. Mycoplasma pneumoniae  pneumonia (MPP) is generally considered to be a mild and self-limiting disease, but it may also show more severe symptoms such as high fever, dry cough,          dyspnea and wheezing，among young patients, the mortality rate and incidence of complications are higher<xref ref-type="bibr" rid="ridm1841917884">2</xref>.It can also cause serious extrapulmonary complications of the circulatory, digestive, blood, urinary, neurological, musculoskeletal, cutaneous mucosal, and other systems <xref ref-type="bibr" rid="ridm1841930996">3</xref></p>
      <p>Bronchoalveolar lavage (BAL) is a safe, easy to operate, minimally invasive and well tolerated technical means, is an important diagnostic tool for respiratory diseases, can promote the diagnosis of various lung diseases <xref ref-type="bibr" rid="ridm1842020484">4</xref><xref ref-type="bibr" rid="ridm1841777164">5</xref>. By analyzing the bronchoalveolar lavage fluid（BALF）, the investigators can determine the cytological component profile and detect respiratory pathogens. Analysis of BALF facilitates the diagnosis of lung infection and provides cytological morphology and other findings that facilitate the diagnosis and management of multiple lung diseases, but the results of BALF analysis must be used in combination with other relevant clinical indicators, such as clinical presentation, medical history, physical examination and radiological findings, etc <xref ref-type="bibr" rid="ridm1841772772">6</xref>. This paper aims to investigate the changes in cell morphology in BALF and its relationship with extrapulmonary manifestations in children with MPP.</p>
    </sec>
    <sec id="idm1841396100" sec-type="materials">
      <title>Materials and methods</title>
      <p>1. <italic>Normal information: </italic>As the study object, we selected children with acute MPP admitted to the      pediatrics and PICU of Xinxiang Medical College from December 2021 to May 2022, and selected children with bronchial foreign bodies treated in the same period as the control group. This study was approved by the hospital ethics committee (approval number: 2021022), and all the parents or guardians of the participating patients gave the informed consent and signed the informed consent form.</p>
      <p>2. Inclusion criteria: (1) refer to the relevant consensus and specifications <xref ref-type="bibr" rid="ridm1841762772">7</xref><xref ref-type="bibr" rid="ridm1841758596">8</xref> Children with acute MPP who meets the diagnostic criteria for mycoplasma pneumoniae pneumonia; (2) the age limit is             between 1 month and 14 years; (3) meets the indication of bronchoalveolar lavage<sup>[</sup><sup>9]</sup>. </p>
      <p>3. <italic>Exclusion criteria: </italic>(1) cases with cardiovascular disease, chronic lung disease, bronchial asthma, and tuberculosis; (2) cases with bacterial and viral infection; (3) cases with congenital immune  deficiency; (4) cases with incomplete clinical data collection;  (5) disapproval from family                   members.</p>
      <p>4. <italic>Research methods</italic></p>
      <p>(1) General clinical data</p>
      <p>Clinical data of 42 included cases (32 patients in the study group and 10 patients in the control group), including general clinical data including age, sex, body weight, duration of fever, hospital stay, MP              antibody, MP load in BALF (&lt;500copies / ml negative), CBC, CRP, LDH, D-dimer, extrapulmonary manifestations, etc.</p>
      <p>(2) Experimental method</p>
      <p> After taking the lavage fluid sample, it was filtered with sterile gauze and placed in a 10ml centrifuge tube. The centrifuge tube was marked and put into the normal temperature centrifuge (Ronghua                    Instrument Manufacturing Co., LTD., China) for centrifugation. About 50μl of the bottom sediment was left for production. If it cannot be detected in time, the room temperature can be stored for 4 hours.</p>
      <p>After mixing the residual sediment evenly, 5~10μl was put into the slide (SAIL BRAND, China). The Swiss-Jimsa staining solution produced by Beso Biotechnology Co., Ltd. of Zhuhai was dried after the push sheet and processed in strict accordance with the reagent instructions. Using an optical microscope (Ningbo Yongxin Optics Co., LTD., China), the stained dry smear was observed, the uniform                     distribution of cells was selected, at least 200 cells (neutrophils, lymphocytes, macrophages, etc.) were counted, and the classification results were reported as a percentage.</p>
      <p>5 <italic>Statistical </italic><italic>method</italic>: The SPSS 26.0 software was used for statistical analysis. The chi-squared test was used to analyse the clinical characteristics of the groups. Qualitative data were expressed as percentages (%), and comparisons between groups were made using the chi-squared test. Quantitative data that                conformed to the normal distribution and chi-squared test results were expressed as the mean±standard deviation  using the independent samples t-test, and those that did not conform to the normal                distribution were expressed as the median-quartile spacing using the nonparametric rank-sum test.A             <italic>P</italic>-value &lt;0.05 was considered a statistically significant difference.</p>
    </sec>
    <sec id="idm1841399988" sec-type="results">
      <title>Results</title>
      <p>1<italic> Comparison of cell morphology in bronchoalveolar lavage fluid between the study group (32 cases) and the control group (10 cases)</italic></p>
      <p>Between study and control groups: There was no statistically significant difference in gender, age, height, and weight between the two groups (<italic>P</italic>&gt; 0. 05). The GRA%, CRP, D-dimer, and LDH in the blood of the study group were significantly higher than those in the control group, while the LM% in the blood routine was lower than that in the control group, and the differences were statistically                     significant (<italic>P </italic>&lt;0.05). Significant differences in the proportion of BALF neutrophils and macrophages (%) in the study group (<italic>P </italic>&lt;0.05), while the difference in he proportion of BALF lymphocyte (%) was not statistically significant (<italic>P</italic>&gt; 0. 05). (<xref ref-type="table" rid="idm1849342076">Table 1</xref>).</p>
      <table-wrap id="idm1849342076">
        <label>Table 1.</label>
        <caption>
          <title> Comparison of clinical data and cell classification counts in BALF between study group and control children</title>
        </caption>
        <table rules="all" frame="box">
          <tbody>
            <tr>
              <td>Clinical characteristics</td>
              <td>Study group (n=32)</td>
              <td>Control group (n=10)</td>
              <td>
                <italic>c</italic>
                <sup>2</sup>
              </td>
              <td>t/Z</td>
              <td>
                <italic>P</italic>
              </td>
            </tr>
            <tr>
              <td>Gender (male / female)</td>
              <td>16/16</td>
              <td>6/4</td>
              <td>0.631</td>
              <td> </td>
              <td>0.384</td>
            </tr>
            <tr>
              <td>Age(years)</td>
              <td>6.6±2.5</td>
              <td>5.7±5.4</td>
              <td> </td>
              <td>-0.653</td>
              <td>0.528</td>
            </tr>
            <tr>
              <td>Height(cm)</td>
              <td>122.7±21.1</td>
              <td>110.8±37.4</td>
              <td> </td>
              <td>-1.229</td>
              <td>0.227</td>
            </tr>
            <tr>
              <td> Weight( kg)</td>
              <td>20.8（18.80，27.53）</td>
              <td>12（9.75，34）</td>
              <td> </td>
              <td>-1.023</td>
              <td>0.307</td>
            </tr>
            <tr>
              <td>Proportion of BALF neutrophils (%)</td>
              <td>46.00（38.00，55.00）</td>
              <td>1.00（0.00，1.75）</td>
              <td> </td>
              <td>-4.504</td>
              <td>＜0.001</td>
            </tr>
            <tr>
              <td> Proportion of BALF lymphocytes (%)</td>
              <td>11.00（10.00，14.00）</td>
              <td>11.50（9.75，14.00）</td>
              <td> </td>
              <td>-0.235</td>
              <td>0.817</td>
            </tr>
            <tr>
              <td>Proportion of BALF macrophages (%)</td>
              <td>43.00（33.87，51.00）</td>
              <td>87.51（85.00，90.00）</td>
              <td> </td>
              <td>-4.503</td>
              <td>＜0.001</td>
            </tr>
            <tr>
              <td>GRA% in blood</td>
              <td>71.04（56.40，79.83）</td>
              <td>46.51（34.50，62.45）</td>
              <td> </td>
              <td>-2.400</td>
              <td>0.016</td>
            </tr>
            <tr>
              <td>LM% in routine blood</td>
              <td>23.44（13.55，34.95）</td>
              <td>43.22（33.10, 58.55）</td>
              <td> </td>
              <td>-2.667</td>
              <td>0.008</td>
            </tr>
            <tr>
              <td>CRP（mg/L）</td>
              <td>17.48（4.86，37.65）</td>
              <td>1.00（0.17，1.64）</td>
              <td> </td>
              <td>-3.834</td>
              <td>＜0.001</td>
            </tr>
            <tr>
              <td>D-dimer (ug/ml)</td>
              <td>1.75（0.80，4.23）</td>
              <td>0.60（0.55，0.75）</td>
              <td> </td>
              <td>-3.375</td>
              <td>0.001</td>
            </tr>
            <tr>
              <td>LDH （U/L）</td>
              <td>342（269，482）</td>
              <td>245（181，284）</td>
              <td> </td>
              <td>-2.967</td>
              <td>0.003</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="idm1841312684">
            <label/>
            <p>Note: GRA: percentage of neutrophils; LM: percentage of lymphocytes; CRP: C reactive protein; LDH: lactate dehydrogenase.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>2 Comparison of the children with and without extrapulmonary manifestations in the study group</p>
      <p>The difference in age between the two groups was not statistically significant (<italic>P </italic>&gt; 0.05). The blood procalcitonin (PCT), LDH and azotransferase (AST) levels and the length of hospitalisation in the group with extrapulmonary manifestations were higher than those in the group without extrapulmonary                    manifestations, with a statistically significant difference (<italic>P</italic> &lt; 0.05). However, the serum albumin level and the proportion of lymphocytes in the BALF in the group with extrapulmonary manifestations were lower than those in the group without extrapulmonary manifestations. The differences were statistically significant (<italic>P</italic> &lt; 0.05),as shown in <xref ref-type="table" rid="idm1849255604">Table 2</xref>.</p>
      <table-wrap id="idm1849255604">
        <label>Table 2.</label>
        <caption>
          <title> Comparison of clinical data and proportion level of cell classification in groups with and without lung manifestations and BALF</title>
        </caption>
        <table rules="all" frame="box">
          <tbody>
            <tr>
              <td>Clinical characteristics</td>
              <td>Group with extra                        pulmonary manifestations (n=8)</td>
              <td>Group without                        extrapulmonary                    manifestations (n=24)</td>
              <td>
                <italic>Z</italic>
              </td>
              <td>
                <italic>P</italic>
              </td>
            </tr>
            <tr>
              <td>Length of hospitalization(days)</td>
              <td>19.00（18.00，22.00）</td>
              <td>11.00（7.00，16.00）</td>
              <td>-3.001</td>
              <td>0.003</td>
            </tr>
            <tr>
              <td>PCT（ng/ml）</td>
              <td>0.74（0.42，3.59）</td>
              <td>0.35（0.19，0.68）</td>
              <td>-2.625</td>
              <td>0.009</td>
            </tr>
            <tr>
              <td>LDH（U/L）</td>
              <td>697.0（469.0，1177.0）</td>
              <td>296.0（255.0，417.0）</td>
              <td>-3.163</td>
              <td>0.002</td>
            </tr>
            <tr>
              <td>AST（U/L）</td>
              <td>54.0（42.0，109.0）</td>
              <td>30.0（22.0，37.0）</td>
              <td>-2.898</td>
              <td>0.004</td>
            </tr>
            <tr>
              <td>albumin (g/L)</td>
              <td>33.9（27.3，40.2）</td>
              <td>40.3（37.1，42.3）</td>
              <td>-2.158</td>
              <td>0.031</td>
            </tr>
            <tr>
              <td>Proportion of BALF neutrophils (%)</td>
              <td>45.00（37.50，59.00）</td>
              <td>.50.0046（38，54.00）</td>
              <td>-0.172</td>
              <td>0.864</td>
            </tr>
            <tr>
              <td> Proportion of BALF                         lymphocytes (%)</td>
              <td>10.50（9.50，11.00）</td>
              <td>13.00（10.00，14.50）</td>
              <td>-2.220</td>
              <td>0.026</td>
            </tr>
            <tr>
              <td>Proportion of BALF                         macrophages (%)</td>
              <td>44.00（31.00，52.00）</td>
              <td>42.50（34.50，51.00）</td>
              <td>-0.123</td>
              <td>0.902</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="idm1841266620">
            <label/>
            <p>Note: PCT:calcitonin; LDH:lactate dehydrogenase; AST: glutamate aminotransferase.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
    </sec>
    <sec id="idm1841265468" sec-type="discussion">
      <title>Discussion</title>
      <p>In recent years, the incidence of Mycoplasma pneumoniae pneumonia (MPP) has been gradually                    increasing among children and adolescents in China, accounting for 10%-40% of community-acquired pneumonia (CAP). Additionally, there is an increasing trend in refractory Mycoplasma pneumoniae pneumonia and severe Mycoplasma pneumoniae pneumonia <xref ref-type="bibr" rid="ridm1841747060">10</xref>. Therefore, timely assessment and                  intervention of airway inflammation are of significant importance for improving the prognosis of                  affected children. Bronchoalveolar lavage (BAL), a non-invasive and well-tolerated method, can obtain samples from the lower respiratory tract. By analyzing bronchoalveolar lavage fluid (BALF),   researchers can determine the cytological composition and detect respiratory pathogens. BAL plays a crucial role in the diagnosis of respiratory tract infections and can also be used to monitor lung                       allografts and evaluate pediatric lung diseases. Examination of BALF cells or non-cellular components through gene microarray technology or proteomics analysis may enhance BALF's diagnostic and                   management role in pulmonary diseases in the near future<xref ref-type="bibr" rid="ridm1841752892">11</xref>.</p>
      <p> The airway inflammatory response in children with MPP is associated with levels of CRP, white blood cells, and neutrophils in the blood, reflecting the body's immune response to bacterial infection<xref ref-type="bibr" rid="ridm1841750876">12</xref><xref ref-type="bibr" rid="ridm1841717588">13</xref>. Some studies suggest that these indicators can serve as a rapid method to differentiate between bacterial and viral pneumonia, provided that appropriate detection thresholds are set based on clinical                        presentation <xref ref-type="bibr" rid="ridm1841715212">14</xref>. However, other research has found no significant differences in these indicators                  between bacterial and viral pneumonia, highlighting the limitation of relying solely on these markers to determine the etiology of pneumonia<xref ref-type="bibr" rid="ridm1841711180">15</xref>. Timely identification of pneumonia etiology can improve   clinical management, including decisions regarding antibiotic use. Most studies indicate that clinical signs and symptoms of bacterial pneumonia and suspected viral pneumonia overlap, and inflammatory response in MPP children, this study collected bronchoalveolar lavage fluid (BALF)    samples from 32 MPP patients and 10 patients with bronchial foreign body aspiration, analyzing their cellular characteristics. It was found that in MPP patients, the proportion of neutrophils in BALF                significantly increased, while the proportion of alveolar macrophages significantly decreased, with no significant difference in lymphocyte proportion, suggesting that neutrophils may play a crucial role in the pathogenesis of MPP. Additionally, levels of CRP, IL-6, white blood cell count, lactate                              dehydrogenase, and D-dimer in the blood were significantly elevated in MPP patients. These results indicate a pronounced airway inflammatory response in MPP patients, consistent with previous research<xref ref-type="bibr" rid="ridm1841721044">17</xref>. Recent evidence suggests that the pathogenesis of Mycoplasma pneumoniae infection is closely related to toll-like receptor stimulation of macrophages by releasing immunomodulatory and                          inflammatory cytokines and chemokines. Following infection, alveolar macrophages are locally                   attracted and activated, leading to the release of pro-inflammatory cytokines and chemokines, resulting in monocytic inflammation and airway hyperreactivity <xref ref-type="bibr" rid="ridm1841702204">18</xref>. With the increasing severity of MPP, the proportion of pulmonary macrophages decreases, indicating a suppression of macrophage activity                  during MPP infection. This may be related to restricted migration or altered gene expression of                    macrophages during MPP <xref ref-type="bibr" rid="ridm1841698532">19</xref>.</p>
      <p> In this study, it was found that MPP patients with extra-pulmonary manifestations had significantly longer hospitalization durations, higher levels of PCT, LDH, and AST, and lower levels of albumin and lymphocyte proportion in BALF compared to MPP patients without extra-pulmonary manifestations, with all differences being statistically significant (<italic>p</italic>&lt;0.05). These results suggest that MPP patients with extra-pulmonary manifestations exhibit more severe systemic inflammatory responses and organ                 damage. The proportion of lymphocytes in BALF showed a negative correlation with the occurrence of extra-pulmonary manifestations, which may reflect the role of lymphocytes in inhibiting immune                 damage caused by MP infection. MP infection can result in various extra-pulmonary manifestations, primarily involving the gastrointestinal tract and skin, while neurological symptoms such as headaches are commonly observed in school-aged children. Other extra-pulmonary manifestations such as cardiac damage, renal impairment, and hematological disorders show no significant differences between                    pre-school and school-aged children,The observed extra-pulmonary manifestations in this study are consistent with the aforementioned findings<xref ref-type="bibr" rid="ridm1841696516">20</xref>.The immune damage caused by MP infection may be related to the similarity in antigenic composition between glycerophospholipids on the MP membrane and host cells, leading to the production of autoantibodies and activation of autoimmune reactions, thereby resulting in multi-system damage <xref ref-type="bibr" rid="ridm1841708252">21</xref>.Some studies have also found that LDH levels and                     hospitalization durations in MPP patients with extra-pulmonary manifestations are significantly higher than those without extra-pulmonary manifestations, consistent with the results of this study <xref ref-type="bibr" rid="ridm1841706092">22</xref>.</p>
      <p> In summary, during the acute phase of MPP in children, BALF is predominantly characterized by               neutrophils. A lower proportion of lymphocytes in BALF is associated with a higher likelihood of                extra-pulmonary manifestations and longer hospitalization duration in MPP patients.</p>
    </sec>
    <sec id="idm1841262516">
      <title>Declarations</title>
      <sec id="idm1841262588">
        <title>Authors’ contributions</title>
        <p>Conception and design of the work: MK; Data collection: MK; Supervision: MK; Analysis and in terpretation of the data: MK; Statistical analysis: MK; Drafting the manuscript: MK; Critical revision of the manuscript: MK, LSJ; Approval of the final manuscript: all authors. </p>
      </sec>
      <sec id="idm1841260860">
        <title>Data availability</title>
        <p>All data generated or analyzed during this study are included in this published article.</p>
      </sec>
      <sec id="idm1841261148">
        <title>Acknowledgement</title>
        <p>Ethics approval and consent to participate. This study was conducted in accordance with the declaration of Helsinki and approved by the Ethics Committee of the First Affiliated Hospital of Xinxiang Medical University(2021022), and with informed consent from the guardians. </p>
      </sec>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="ridm1841922852">
        <label>1.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Y</surname>
            <given-names>T Lv</given-names>
          </name>
          <name>
            <surname>X</surname>
            <given-names>J Sun</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Y</given-names>
          </name>
          <article-title>et al.Epidemic characteristics of Mycoplasma pneumoniae infection: a retrospective analysis of a single center in Suzhou from 2014 to 2020 [J].Annals of translational medicine</article-title>
          <date>
            <year>2022</year>
          </date>
          <volume>10</volume>
          <issue>20</issue>
          <fpage>1123</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841917884">
        <label>2.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Li</surname>
            <given-names>Z J</given-names>
          </name>
          <article-title>Etiological and epidemiological features of acute respiratory infections in China. Nat Commun</article-title>
          <date>
            <year>2021</year>
          </date>
          <volume>12</volume>
          <issue>1</issue>
          <fpage>5026</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841930996">
        <label>3.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Chen</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Yin</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>X</given-names>
          </name>
          <article-title>et al.Thromboembolic complications of Mycoplasma pneumoniae pneumonia in children [J].Clin Respir J</article-title>
          <date>
            <year>2023</year>
          </date>
        </mixed-citation>
      </ref>
      <ref id="ridm1842020484">
        <label>4.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Siddiqui</surname>
            <given-names>S S</given-names>
          </name>
          <name>
            <surname>Sharma</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Khurana</surname>
            <given-names>A K</given-names>
          </name>
          <article-title>Bronchoalveolar Lavage in Diagnostic Evaluation of Pulmonary Diseases- An Institutional Experience</article-title>
          <date>
            <year>2023</year>
          </date>
          <source>J Cytol</source>
          <volume>40</volume>
          <issue>2</issue>
          <fpage>68</fpage>
          <lpage>74</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841777164">
        <label>5.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>S</surname>
            <given-names>P HOGEA</given-names>
          </name>
          <article-title>TUDORACHE E, PESCARU C, et al.Bronchoalveolar lavage: role in the evaluation of pulmonary interstitial disease [J].Expert Rev Respir Med</article-title>
          <date>
            <year>2020</year>
          </date>
          <volume>14</volume>
          <issue>11</issue>
          <fpage>1117</fpage>
          <lpage>30</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841772772">
        <label>6.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>K</surname>
            <given-names>C MEYER</given-names>
          </name>
          <name>
            <surname>RAGHU</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>R</surname>
            <given-names>P BAUGHMAN</given-names>
          </name>
          <article-title>et al.An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease [J].Am J Respir Crit Care Med</article-title>
          <date>
            <year>2012</year>
          </date>
          <volume>185</volume>
          <issue>9</issue>
          <fpage>1004</fpage>
          <lpage>14</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841762772">
        <label>7.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <article-title>Expert group for compiling and approving the diagnosis and treatment norms for community-acquired pneumonia in children</article-title>
          <date>
            <year>2019</year>
          </date>
          <chapter-title>Code for Diagnosis and Treatment of Community-acquired Pneumonia in Children (2019 edition) [J]. Clinical and Education in General Practice</chapter-title>
          <volume>17</volume>
          <issue>9</issue>
          <fpage>771</fpage>
          <lpage>7</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841758596">
        <label>8.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Group</surname>
            <given-names>Respiratory</given-names>
          </name>
          <article-title>Pediatrics Branch of Chinese Medical Association, Editorial Committee of Chinese Journal of Practical Clinical Pediatrics. Expert consensus on the diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children</article-title>
          <date>
            <year>2015</year>
          </date>
          <source>edition) [J]. Chinese Journal of Practical Clinical Pediatrics</source>
          <volume>30</volume>
          <issue>17</issue>
          <fpage>1304</fpage>
          <lpage>8</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841764356">
        <label>9.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <article-title>Technical Expert Group of Pediatric Respiratory Endoscopy Diagnosis and Treatment of Talent Exchange Service Center of</article-title>
          <date>
            <year>2018</year>
          </date>
          <source>National Health Commission, Endoscopy Professional Committee of Pediatrician Branch of Chinese Medical Doctor Association, Pediatric Respiratory Endoscopy Professional Committee of Endoscopy Branch of Chinese Medical Doctor Association, etc. Guidelines</source>
          <volume>33</volume>
          <issue>13</issue>
          <fpage>983</fpage>
          <lpage>9</lpage>
          <publisher-loc>China</publisher-loc>
        </mixed-citation>
      </ref>
      <ref id="ridm1841747060">
        <label>10.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Song</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Jia</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Luo</surname>
            <given-names>G</given-names>
          </name>
          <article-title>Global research trends of Mycoplasma pneumoniae pneumonia in children: a bibliometric analysis. Front Pediatr</article-title>
          <date>
            <year>2023</year>
          </date>
          <volume>11</volume>
          <fpage>1306234</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841752892">
        <label>11.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>K</surname>
            <given-names>R Davidson</given-names>
          </name>
          <name>
            <surname>D</surname>
            <given-names>M Ha</given-names>
          </name>
          <name>
            <surname>M</surname>
            <given-names>I Schwarz</given-names>
          </name>
          <article-title>Bronchoalveolar lavage as a diagnostic procedure: a review of known cellular and molecular findings in various lung diseases [J]. Journal of thoracic disease</article-title>
          <date>
            <year>2020</year>
          </date>
          <volume>12</volume>
          <issue>9</issue>
          <fpage>4991</fpage>
          <lpage>5019</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841750876">
        <label>12.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Thomas</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Pociute</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kevalas</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Blood biomarkers differentiating viral versus bacterial pneumonia aetiology: a literature review [J]. Italian journal of pediatrics</article-title>
          <date>
            <year>2020</year>
          </date>
          <volume>46</volume>
          <issue>1</issue>
          <fpage>4</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841717588">
        <label>13.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>I</surname>
            <given-names>M Ciuca</given-names>
          </name>
          <name>
            <surname>Dediu</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>L</surname>
            <given-names/>
          </name>
          <article-title>Pediatric pneumonia (PedPne) lung ultrasound score and inflammatory markers: A pilot study [J]. Pediatric pulmonology</article-title>
          <date>
            <year>2022</year>
          </date>
          <volume>57</volume>
          <issue>2</issue>
          <fpage>576</fpage>
          <lpage>82</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841715212">
        <label>14.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>M</surname>
            <given-names>U Bhuiyan</given-names>
          </name>
          <name>
            <surname>C</surname>
            <given-names/>
          </name>
          <name>
            <surname>West</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Combination of clinical symptoms and blood biomarkers can improve discrimination between bacterial or viral community-acquired pneumonia in children [J]. BMC Pulm Med</article-title>
          <date>
            <year>2019</year>
          </date>
          <fpage>19</fpage>
          <lpage>1</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841711180">
        <label>15.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Wrotek</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Robakiewicz</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Pawlik</surname>
            <given-names>K</given-names>
          </name>
          <date>
            <year>2022</year>
          </date>
          <chapter-title>The Etiology of Community-Acquired Pneumonia Correlates with Serum Inflammatory Markers in Children [J]. Journal of clinical medicine</chapter-title>
          <fpage>11</fpage>
          <lpage>19</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841722988">
        <label>16.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>K</surname>
            <given-names>W Yun</given-names>
          </name>
          <name>
            <surname>Wallihan</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Desai</surname>
            <given-names>A</given-names>
          </name>
          <article-title>[J]. The Pediatric infectious disease journal</article-title>
          <date>
            <year>2015</year>
          </date>
          <chapter-title>Clinical Characteristics and Etiology of Community-acquired Pneumonia in US Children</chapter-title>
          <volume>41</volume>
          <issue>5</issue>
          <fpage>381</fpage>
          <lpage>7</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841721044">
        <label>17.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Shanthikumar</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Burton</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Saffery</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Single-cell flow cytometry profiling of BAL in children [J]. American journal of respiratory cell and molecular biology</article-title>
          <date>
            <year>2020</year>
          </date>
          <volume>63</volume>
          <issue>2</issue>
          <fpage>152</fpage>
          <lpage>9</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841702204">
        <label>18.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Wang</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>X</given-names>
          </name>
          <article-title>Diagnostic value of serum LDH in children with refractory Mycoplasma pneumoniae pneumoniae: A systematic review and meta-analysis [J]. Frontiers in pediatrics</article-title>
          <date>
            <year>2023</year>
          </date>
          <volume>11</volume>
          <fpage>1094118</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841698532">
        <label>19.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Zhang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Dou</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Tu</surname>
            <given-names>P</given-names>
          </name>
          <article-title>Serum cytokine profiling reveals different immune response patterns during general and severe Mycoplasma pneumoniae pneumonia. Front Immunol</article-title>
          <date>
            <year>2022</year>
          </date>
          <volume>13</volume>
          <fpage>1088725</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841696516">
        <label>20.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Biagi</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Cavallo</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Rocca</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Pulmonary and extrapulmonary manifestations in hospitalized children with Mycoplasma pneumoniae infection</article-title>
          <date>
            <year>2021</year>
          </date>
          <volume>9</volume>
          <issue>12</issue>
          <fpage>2553</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841708252">
        <label>21.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Zhai</surname>
            <given-names>Y-Y</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>S-Z</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>Y</given-names>
          </name>
          <article-title>An analysis of 20 clinical cases of refractory mycoplasma pneumonia in children [J]. Ann Palliat Med</article-title>
          <date>
            <year>2020</year>
          </date>
          <volume>9</volume>
          <issue>5</issue>
          <fpage>2592</fpage>
          <lpage>9</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841706092">
        <label>22.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Lee</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Choi</surname>
            <given-names>I</given-names>
          </name>
          <article-title>Clinical Usefulness of Serum Lactate Dehydrogenase Levels in Mycoplasma pneumoniae Pneumonia in Children [J]</article-title>
          <date>
            <year>2022</year>
          </date>
          <source>Indian Journal of Pediatrics</source>
          <volume>89</volume>
          <issue>10</issue>
          <fpage>1003</fpage>
          <lpage>9</lpage>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
